- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期行情可能回暖，可适量买进股票，作短线反弹行情。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有70家主力机构披露2025-12-31报告期持股数据，持仓量总计1.78亿股，占流通A股44.06%
- 波段诊断：
-
技术面诊股
诊断结果：5.1技术面打败了63%的股票
技术面评分前10的股票
近期的平均成本为5.78元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为5.78元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.78","date":1782634988,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑输行业平均水平。
[{"date":"2026.06.29","stock":"2.61","trade":null,"ind":"0.19"},{"date":"2026.06.26","stock":"-3.36","trade":null,"ind":"-3.44"},{"date":"2026.06.25","stock":"-1.16","trade":null,"ind":"1.82"},{"date":"2026.06.24","stock":"-3.99","trade":null,"ind":"1.24"},{"date":"2026.06.23","stock":"1.13","trade":null,"ind":"-3.17"},{"date":"2026.06.22","stock":"1.31","trade":null,"ind":"2.13"},{"date":"2026.06.18","stock":"0.49","trade":null,"ind":"0.94"},{"date":"2026.06.17","stock":"-3.03","trade":null,"ind":"1.31"},{"date":"2026.06.16","stock":"1.29","trade":null,"ind":"0.93"},{"date":"2026.06.15","stock":"-2.97","trade":null,"ind":"3.79"},{"date":"2026.06.12","stock":"3.23","trade":null,"ind":"0.75"},{"date":"2026.06.11","stock":"-0.48","trade":null,"ind":"-0.68"},{"date":"2026.06.10","stock":"-2.35","trade":null,"ind":"-2.06"},{"date":"2026.06.09","stock":"1.92","trade":null,"ind":"3.02"},{"date":"2026.06.08","stock":"-3.25","trade":null,"ind":"-3.22"},{"date":"2026.06.05","stock":"0.47","trade":null,"ind":"-2.21"},{"date":"2026.06.04","stock":"-2.13","trade":null,"ind":"-0.27"},{"date":"2026.06.03","stock":"-1.94","trade":null,"ind":"0.73"},{"date":"2026.06.02","stock":"-2.61","trade":null,"ind":"1.63"},{"date":"2026.06.01","stock":"2.99","trade":null,"ind":"-1.51"},{"date":"2026.05.29","stock":"-2.76","trade":null,"ind":"-1.81"}]
易瑞生物,深证成指,医疗器械指数
压力支撑
该股压力位为5.69元，支撑位为5.48元。
[{"text":"\u538b\u529b\u4f4d","value":"5.69","date":1782662400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.48","date":1782662400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.6资金面打败了64%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月29日 20:30
| 机构今日流向(万元) | 910.80 | 机构5日流向(万元) | -2655.42 |
| 机构10日流向(万元) | -5662.96 | 机构20日流向(万元) | -10152.07 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少825.08万股，其中基金净减仓1家，主力净增仓30家，暂未发现中长期投资价值。
截止2025-12-31，共70家主力机构（基金65家，其他资管计划1家，QFII1家，一般法人3家），持仓量总计17847.61万股，占流通A股44.06%
其中，基金持仓与2025-06-30相比：
增仓：5家 ，增持 17.76万股
减仓：6家 ，减持 38.10万股
新出现在主力名单中：51家 ，持有525.2万股
从主力名单中消失：21家 ，原持有373.48万股
其中，基金持仓与2025-06-30相比：
增仓：5家 ，增持 17.76万股
减仓：6家 ，减持 38.10万股
新出现在主力名单中：51家 ，持有525.2万股
从主力名单中消失：21家 ，原持有373.48万股
消息面诊股
诊断结果：5.6消息面打败了39%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 易瑞生物：6月26日获融资买入498.12万元
2026-06-29 - 易瑞生物：6月25日获融资买入413.88万元
2026-06-26 - 易瑞生物：6月24日获融资买入420.20万元
2026-06-25 - 易瑞生物：6月23日获融资买入455.95万元
2026-06-24 - 易瑞生物：6月22日获融资买入401.46万元
2026-06-23 - 易瑞生物：6月18日获融资买入286.07万元
2026-06-22 - 易瑞生物：6月17日获融资买入349.19万元
2026-06-18 - 易瑞生物：公司将持续推进国际化战略，深化海外市场拓
2026-06-17 - 易瑞生物：公司部分产品取得欧盟ILVO、美国AOA
2026-06-17 - 易瑞生物：公司销售网络已覆盖欧洲亚洲非洲美洲等70
2026-06-17
消息列表
| 一般消息 | 募资投向 | 2026-06-04 | |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-27 |
| 利好 | 分红转增 | 10派0.246794元(含税) | 2026-04-27 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-04-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-04-09 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-02-03 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-02-02 |
| 一般消息 | 高管变动 | 公司治理结构调整 | 2025-09-15 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了4%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.06.29","price":"0.19","value":null},{"date":"2026.06.26","price":"-3.44","value":null},{"date":"2026.06.25","price":"1.82","value":null},{"date":"2026.06.24","price":"1.24","value":null},{"date":"2026.06.23","price":"-3.17","value":null},{"date":"2026.06.22","price":"2.13","value":null},{"date":"2026.06.18","price":"0.94","value":null},{"date":"2026.06.17","price":"1.31","value":null},{"date":"2026.06.16","price":"0.93","value":null},{"date":"2026.06.15","price":"3.79","value":null},{"date":"2026.06.12","price":"0.75","value":null},{"date":"2026.06.11","price":"-0.68","value":null},{"date":"2026.06.10","price":"-2.06","value":null},{"date":"2026.06.09","price":"3.02","value":null},{"date":"2026.06.08","price":"-3.22","value":null},{"date":"2026.06.05","price":"-2.21","value":null},{"date":"2026.06.04","price":"-0.27","value":null},{"date":"2026.06.03","price":"0.73","value":null},{"date":"2026.06.02","price":"1.63","value":null},{"date":"2026.06.01","price":"-1.51","value":null},{"date":"2026.05.29","price":"-1.81","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 爱迪特 | 69.26% | -8.11% | 6.0分 |
| 2 | 力诺药包 | 49.86% | -7.36% | 4.7分 |
| 3 | 正川股份 | 24.98% | -3.73% | 4.8分 |
| 4 | 仁度生物 | 14.73% | -1.06% | 5.2分 |
| 5 | 洁特生物 | 12.77% | -2.31% | 5.0分 |
| 6 | 伟思医疗 | 12.73% | 5.43% | 5.8分 |
| 8 | 迈普医学 | 10.48% | 10.68% | 5.1分 |
| 10 | 英诺特 | 8.45% | 4.82% | 4.7分 |
| 12 | 大博医疗 | 6.13% | 3.21% | 5.8分 |
| 14 | 美好医疗 | 3.58% | -6.89% | 5.0分 |
| 16 | 可孚医疗 | 1.13% | 6.29% | 5.7分 |
| 18 | 华大智造 | 0.85% | 0.47% | 4.9分 |
| 20 | 拱东医疗 | 0.77% | 18.96% | 5.9分 |
| 22 | - | -0.26% | -2.46% | 分 |
| 24 | 冠昊生物 | -0.59% | 7.39% | 5.4分 |
| 26 | 澳华内镜 | -0.92% | 2.42% | 5.4分 |
| 28 | 天益医疗 | -1.76% | -3.52% | 5.2分 |
| 30 | 乐普医疗 | -2.49% | 4.21% | 5.3分 |
| 32 | 利德曼 | -3.03% | 0.88% | 4.4分 |
| 34 | 康德莱 | -3.55% | -0.70% | 4.7分 |
| 36 | 九强生物 | -4.17% | -0.18% | 4.7分 |
| 38 | 戴维医疗 | -4.41% | 1.46% | 5.2分 |
| 40 | 安杰思 | -5.15% | -2.14% | 4.8分 |
| 42 | - | -5.54% | -1.92% | 分 |
| 44 | 南卫股份 | -5.95% | 3.34% | 4.9分 |
| 46 | 天智航 | -6.58% | -15.63% | 3.5分 |
| 48 | 五洲医疗 | -6.78% | -11.79% | 3.7分 |
| 50 | 正海生物 | -6.91% | 0.34% | 4.8分 |
| 52 | 艾德生物 | -7.15% | 2.49% | 5.0分 |
| 54 | 康泰医学 | -7.24% | -7.72% | 4.1分 |
| 56 | 理邦仪器 | -7.56% | -5.17% | 5.2分 |
| 58 | 维力医疗 | -8.04% | 0.35% | 5.0分 |
| 60 | 国发股份 | -8.24% | -0.51% | 4.7分 |
| 62 | 新华医疗 | -8.83% | 2.16% | 5.1分 |
| 64 | 南微医学 | -8.87% | 7.67% | 5.5分 |
| 66 | 美康生物 | -9.10% | -0.60% | 4.8分 |
| 68 | 康众医疗 | -9.15% | 3.20% | 4.3分 |
| 70 | 开立医疗 | -9.50% | -3.02% | 4.3分 |
| 72 | 三诺生物 | -9.70% | -1.61% | 5.4分 |
| 74 | ST凯利 | -9.91% | 2.18% | 5.1分 |
| 76 | 天臣医疗 | -10.02% | -3.75% | 4.5分 |
| 78 | *ST明德 | -10.26% | -3.00% | 4.0分 |
| 80 | 九安医疗 | -10.46% | -8.30% | 4.8分 |
| 82 | 基蛋生物 | -10.62% | -1.51% | 5.3分 |
| 84 | 健帆生物 | -10.98% | 0.58% | 4.6分 |
| 86 | 迈克生物 | -11.43% | -2.11% | 4.7分 |
| 88 | 麦澜德 | -11.67% | -13.92% | 3.5分 |
| 90 | 中源协和 | -11.81% | -2.45% | 4.6分 |
| 92 | 瑞迈特 | -11.94% | -3.69% | 4.6分 |
| 94 | 科美诊断 | -12.08% | -1.69% | 4.4分 |
| 96 | 凯普生物 | -12.33% | -5.61% | 4.5分 |
| 98 | 透景生命 | -12.90% | -3.11% | 4.7分 |
| 100 | 亚辉龙 | -13.23% | -1.00% | 4.7分 |
| 102 | 超研股份 | -13.27% | -5.11% | 4.8分 |
| 104 | 健尔康 | -13.52% | -2.11% | 4.8分 |
| 106 | 黄山胶囊 | -13.73% | -4.94% | 4.9分 |
| 108 | 博拓生物 | -13.99% | -9.03% | 3.5分 |
| 110 | 康拓医疗 | -14.34% | -5.85% | 3.8分 |
| 112 | 硕世生物 | -14.67% | -7.36% | 4.4分 |
| 114 | 华强科技 | -14.90% | -8.19% | 3.6分 |
| 116 | 东方生物 | -15.19% | -3.87% | 4.4分 |
| 118 | 西山科技 | -15.52% | -16.55% | 3.4分 |
| 120 | - | -15.86% | -8.90% | 分 |
| 122 | 济高发展 | -16.25% | -7.20% | 4.0分 |
| 124 | 健信超导 | -17.18% | -4.03% | 5.2分 |
| 126 | 港通医疗 | -17.80% | -8.27% | 4.4分 |
| 128 | - | -17.94% | -7.88% | 分 |
| 130 | 万东医疗 | -18.08% | -8.34% | 4.7分 |
| 132 | ST迪瑞 | -20.08% | -3.78% | 4.3分 |
| 134 | 奕瑞科技 | -21.99% | 1.12% | 4.8分 |
| 136 | *ST海利 | -25.28% | -11.92% | 3.1分 |
| 138 | 之江生物 | -29.91% | -4.89% | 3.9分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 118/245 ， 66/245。
[{"date":"2026-03-31","value":"-1.14","vol":"1.15"},{"date":"2025-12-31","value":"1.55","vol":"2.66"},{"date":"2025-09-30","value":"2.03","vol":"2.97"},{"date":"2025-06-30","value":"0.27","vol":"2.34"},{"date":"2025-03-31","value":"-0.39","vol":"1.15"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-1.14 | 1.55 | 2.03 | 0.27 | -0.39 |
| 行业(%) | 1.15 | 2.66 | 2.97 | 2.34 | 1.15 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"55.80","vol":"52.18"},{"date":"2025-12-31","value":"63.98","vol":"51.61"},{"date":"2025-09-30","value":"64.30","vol":"51.74"},{"date":"2025-06-30","value":"64.47","vol":"52.05"},{"date":"2025-03-31","value":"52.37","vol":"51.74"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
55.80 | 63.98 | 64.30 | 64.47 | 52.37 |
| 行业(%) | 52.18 | 51.61 | 51.74 | 52.05 | 51.74 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 31/245 ， 120/245。
[{"date":"2026-03-31","value":"16.82","vol":"5.49"},{"date":"2025-12-31","value":"17.38","vol":"1.44"},{"date":"2025-09-30","value":"17.45","vol":"0.26"},{"date":"2025-06-30","value":"5.44","vol":"-1.09"},{"date":"2025-03-31","value":"35.28","vol":"-0.12"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
16.82 | 17.38 | 17.45 | 5.44 | 35.28 |
| 行业(%) | 5.49 | 1.44 | 0.26 | -1.09 | -0.12 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-206.62","vol":"-16.14"},{"date":"2025-12-31","value":"-19.71","vol":"-25.45"},{"date":"2025-09-30","value":"362.49","vol":"-15.37"},{"date":"2025-06-30","value":"250.02","vol":"-18.14"},{"date":"2025-03-31","value":"52.95","vol":"-2.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-206.62 | -19.71 | 362.49 | 250.02 | 52.95 |
| 行业(%) | -16.14 | -25.45 | -15.37 | -18.14 | -2.57 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 112/245 ， 73/245。
[{"date":"2026-03-31","value":"0.04","vol":"0.08"},{"date":"2025-12-31","value":"0.18","vol":"0.35"},{"date":"2025-09-30","value":"0.13","vol":"0.25"},{"date":"2025-06-30","value":"0.08","vol":"0.17"},{"date":"2025-03-31","value":"0.03","vol":"0.08"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.04 | 0.18 | 0.13 | 0.08 | 0.03 |
| 行业(次) | 0.08 | 0.35 | 0.25 | 0.17 | 0.08 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.44","vol":"0.55"},{"date":"2025-12-31","value":"1.99","vol":"2.33"},{"date":"2025-09-30","value":"1.35","vol":"1.66"},{"date":"2025-06-30","value":"0.83","vol":"1.12"},{"date":"2025-03-31","value":"0.58","vol":"0.54"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.44 | 1.99 | 1.35 | 0.83 | 0.58 |
| 行业(次) | 0.55 | 2.33 | 1.66 | 1.12 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"-21.73","vol":"0.09"},{"date":"2025-12-31","value":"76.09","vol":"32.02"},{"date":"2025-09-30","value":"10.28","vol":"14.74"},{"date":"2025-06-30","value":"2.33","vol":"15.54"},{"date":"2025-03-31","value":"-2.87","vol":"4.16"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -21.73 | 76.09 | 10.28 | 2.33 | -2.87 |
| 行业 | 0.09 | 32.02 | 14.74 | 15.54 | 4.16 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.50","vol":"1.59"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"1.67","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.50 | - | 1.67 | - |
| 行业 | 0.00 | 1.59 | 0.01 | 1.57 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 93/245 ， 99/245。
[{"date":"2026-03-31","value":"7.29","vol":"6.20"},{"date":"2025-12-31","value":"5.09","vol":"5.29"},{"date":"2025-09-30","value":"5.16","vol":"5.66"},{"date":"2025-06-30","value":"6.41","vol":"5.47"},{"date":"2025-03-31","value":"5.47","vol":"5.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
7.29 | 5.09 | 5.16 | 6.41 | 5.47 |
| 行业 | 6.20 | 5.29 | 5.66 | 5.47 | 5.80 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"6.46","vol":"5.06"},{"date":"2025-12-31","value":"4.63","vol":"4.14"},{"date":"2025-09-30","value":"4.66","vol":"4.51"},{"date":"2025-06-30","value":"5.78","vol":"4.35"},{"date":"2025-03-31","value":"5.00","vol":"4.69"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
6.46 | 4.63 | 4.66 | 5.78 | 5.00 |
| 行业 | 5.06 | 4.14 | 4.51 | 4.35 | 4.69 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 13/245 ， 14/245。
[{"date":"2026-03-31","value":"39.55","vol":"21.96"},{"date":"2025-12-31","value":"40.46","vol":"22.90"},{"date":"2025-09-30","value":"38.55","vol":"22.07"},{"date":"2025-06-30","value":"39.06","vol":"22.01"},{"date":"2025-03-31","value":"39.97","vol":"21.02"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
39.55 | 40.46 | 38.55 | 39.06 | 39.97 |
| 行业(%) | 21.96 | 22.90 | 22.07 | 22.01 | 21.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.66","vol":"0.39"},{"date":"2025-12-31","value":"0.68","vol":"0.40"},{"date":"2025-09-30","value":"0.63","vol":"0.71"},{"date":"2025-06-30","value":"0.64","vol":"0.58"},{"date":"2025-03-31","value":"0.67","vol":"0.56"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.66 | 0.68 | 0.63 | 0.64 | 0.67 |
| 行业(%) | 0.39 | 0.40 | 0.71 | 0.58 | 0.56 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"0.83","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-1.85","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.17","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.14","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.50","blueLineValue":"0.12","type":"YC"}]